Marazziti D - Search Results

1

Italian prescribing patterns in obsessive-compulsive disorder.

Marazziti D, Albert U, Dell'Osso B, Tundo A, Cuniberti F, Maina G, Moroni I, Benatti B, Mucci F, Massimetti G, Piccinni A, Brakoulias V. Marazziti D, et al. Hum Psychopharmacol. 2017 Nov;32(6). doi: 10.1002/hup.2641. Epub 2017 Oct 2. Hum Psychopharmacol. 2017. PMID: 28967153 Free article.

2

Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive-compulsive disorder.

Marazziti D, Rotondo A, Martini C, Giannaccini G, Lucacchini A, Pancioli-Guadagnucci ML, Diamond BI, Borison R, Cassano GB. Marazziti D, et al. Neuropsychobiology. 1994;29(1):8-11. doi: 10.1159/000119055. Neuropsychobiology. 1994. PMID: 8127425

3

Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage.

Lenzi A, Raffaelli S, Marazziti D. Lenzi A, et al. Among authors: marazziti d. Pharmacopsychiatry. 1993 May;26(3):100-1. doi: 10.1055/s-2007-1014351. Pharmacopsychiatry. 1993. PMID: 8415895 No abstract available.

4

Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.

Marazziti D, Rossi A, Gemignani A, Giannaccini G, Pfanner C, Milanfranchi A, Presta S, Lucacchini A, Cassano GB. Marazziti D, et al. Neuropsychobiology. 1996;34(4):184-7. doi: 10.1159/000119308. Neuropsychobiology. 1996. PMID: 9121618

5

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB. Milanfranchi A, et al. Among authors: marazziti d. Int Clin Psychopharmacol. 1997 May;12(3):131-6. doi: 10.1097/00004850-199705000-00002. Int Clin Psychopharmacol. 1997. PMID: 9248868 Clinical Trial.

6

Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine.

Marazziti D, Pfanner C, Palego L, Gemignani A, Milanfranchi A, Ravagli S, Lensi P, Presta S, Cassano GB. Marazziti D, et al. Pharmacopsychiatry. 1997 Nov;30(6):245-9. doi: 10.1055/s-2007-979501. Pharmacopsychiatry. 1997. PMID: 9442546 Clinical Trial.

7

Immunological alterations in adult obsessive-compulsive disorder.

Marazziti D, Presta S, Pfanner C, Gemignani A, Rossi A, Sbrana S, Rocchi V, Ambrogi F, Cassano GB. Marazziti D, et al. Biol Psychiatry. 1999 Sep 15;46(6):810-4. doi: 10.1016/s0006-3223(98)00371-0. Biol Psychiatry. 1999. PMID: 10494449

8

Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study.

Pfanner C, Marazziti D, Dell'Osso L, Presta S, Gemignani A, Milanfranchi A, Cassano GB. Pfanner C, et al. Among authors: marazziti d. Int Clin Psychopharmacol. 2000 Sep;15(5):297-301. doi: 10.1097/00004850-200015050-00007. Int Clin Psychopharmacol. 2000. PMID: 10993132 Clinical Trial.

9

Citalopram in refractory obsessive-compulsive disorder: an open study.

Marazziti D, Dell'Osso L, Gemignani A, Ciapparelli A, Presta S, Nasso ED, Pfanner C, Cassano GB. Marazziti D, et al. Int Clin Psychopharmacol. 2001 Jul;16(4):215-9. doi: 10.1097/00004850-200107000-00005. Int Clin Psychopharmacol. 2001. PMID: 11459335

10

Insight in obsessive-compulsive disorder: a study of an Italian sample.

Marazziti D, Dell'Osso L, Di Nasso E, Pfanner C, Presta S, Mungai F, Cassano GB. Marazziti D, et al. Eur Psychiatry. 2002 Nov;17(7):407-10. doi: 10.1016/s0924-9338(02)00697-1. Eur Psychiatry. 2002. PMID: 12547307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page